Hers is a U.S. telehealth platform from Hims & Hers Health, Inc. (NYSE: HIMS) that connects women with licensed providers and ships prescription treatments directly to their homes. For menopause care, the service offers hormone replacement therapy after an online intake and clinician review.
When appropriate, providers prescribe FDA‑approved options such as estrogen, progesterone, or combination therapy, which are filled through regulated partner pharmacies. Follow‑up care, refills, and messaging with providers are all handled digitally on the platform.
Hers provides prescription hormone replacement therapy (HRT) through a subscription model. Pricing is determined after a licensed provider reviews your medical intake and recommends a treatment plan.
Your cost may vary based on:
Type of hormone prescribed (estrogen, progesterone, or combination therapy)
Formulation (oral tablet, topical cream, etc.)
Dosage strength
Shipment frequency (monthly or multi-month refills)
Before you complete checkout, Hers displays your exact total so you can review the full cost in advance.
All services are self-pay. Hers does not typically bill insurance directly, though eligible HSA or FSA funds may be used.
The process begins with an online intake questionnaire covering medical history, symptoms, medications, and menopause stage. A licensed medical provider reviews the information and may request additional clarification. If deemed appropriate, a personalized HRT prescription is issued.
Medications are shipped directly to the patient’s home in discreet packaging. Ongoing care includes refill management and provider messaging through the platform.
Key elements include:
The platform emphasizes convenience and privacy. A refund or satisfaction policy may apply depending on product type and timing; users must review specific terms at checkout.
Hers operates within applicable U.S. telehealth and state-specific prescribing regulations Prescriptions are issued only if medically appropriate after review by a licensed provider.
The company is publicly traded (NYSE: HIMS), which requires financial transparency and regulatory reporting under U.S. securities law. Prescription medications are dispensed through regulated pharmacy partners.
Hers provides several support channels:
Support availability may vary by state and volume, but customer service typically responds within business days. The FAQ section addresses billing, subscription cancellation, prescription details, and shipping timelines.
Because HRT is prescription-based, provider messaging is integrated into the platform for clinical questions. Emergency medical concerns are directed to local healthcare providers rather than telehealth messaging.
Hers distinguishes itself through:
The company combines menopause care with other services such as mental health support and dermatology, allowing patients to manage multiple needs within one account. As a publicly traded company under Hims & Hers Health, Inc., listed on the NYSE as HIMS, it is required to maintain financial transparency and regulatory reporting under U.S. securities laws.
Individuals requiring complex endocrine evaluation, insurance-based care, or in-person examinations may prefer traditional clinical settings. For many women navigating menopause symptoms, Hers offers accessible treatment options supported by licensed healthcare providers, with prescriptions fulfilled through regulated pharmacy partners.
Having explored the features and benefits of this product, you might be curious about how it stacks up against its competitors. We encourage you to visit our comprehensive comparison chart for a broader perspective. This chart offers a detailed juxtaposition of this product with other leading brands, highlighting differences in features, pricing, and customer ratings. It’s an invaluable resource for contrasting your options and making an informed decision that best suits your needs. Don’t miss out – take a moment now to view our comparison chart and see how your chosen product compares in the wider market.
AI was used in the creation of this content, along with human validation and proofreading.
Emilia Baran, M.D., is a physician with a diverse clinical and research background and has contributed to both academic and community health settings. Dr. Baran volunteers at health clinics, works as a fact-checker for HealthDay News, and participates in multiple clinical research projects.